CRO Lyonnaise depuis 1989" title="" class="btn" data-container="body" data-html="true" data-id="140276" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="RCTs"> 33 2,329
Activities
Technologies
Entity types
Location
38 Rue du Plat, 69002 Lyon, France
Lyon
France
Employees
Scale: 11-50
Estimated: 50
SIREN
351515762Engaged corporates
7Added in Motherbase
4 years agoPartenaire de l’innovation médicale
RCTs is a French and International Full-Service CRO with more than 30 years of experience and over 700 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices.
It is also a stable company whose staff annual renewal rate is less than 10% and the 5 main managers are associates (Frédéric Mistretta, Morgane Champiot, Audrey Lajoinie, Flavien Roux and Didier Not).
IT tools (eCRF, IWRS, ePRO, eTMF, CTMS) are being constantly adapted to the constraints and evolutions of the business and regulations. These tools are developed and maintained by ClinInfo, our daughter company (http://www.clininfo.fr/).
RCTs is also co-founder and shareholder of PSN Research LLC (http://psnresearch.com/), owned by 7 European CROs and one US CRO (France, Germany, Italy, Denmark, Spain, Netherlands, Great Britain, USA). This structure provides you with a unique added value across all these territories and even beyond, through preferred partners in countries not directly covered by PSN Research's parent companies.
Specializations: Clinical studies, Pharmaco-epidemiology, Health economics, Medical Devices, Consulting, Medical Writer, Clinical Evaluation (CEP, CER), CRO, eCRF, IWRS, ePRO and eTMF.
Etudes cliniques, Pharmaco-épidémiologie, Economie de la santé, Dispositifs médicaux, Consulting, CRO, eCRF, IWRS, ePRO, and eTMF
Partenaire de l’innovation médicale
RCTs is a French and International Full-Service CRO with more than 30 years of experience and over 700 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices.
It is also a stable company whose staff annual renewal rate is less than 10% and the 5 main managers are associates (Frédéric Mistretta, Morgane Champiot, Audrey Lajoinie, Flavien Roux and Didier Not).
IT tools (eCRF, IWRS, ePRO, eTMF, CTMS) are being constantly adapted to the constraints and evolutions of the business and regulations. These tools are developed and maintained by ClinInfo, our daughter company (http://www.clininfo.fr/).
RCTs is also co-founder and shareholder of PSN Research LLC (http://psnresearch.com/), owned by 7 European CROs and one US CRO (France, Germany, Italy, Denmark, Spain, Netherlands, Great Britain, USA). This structure provides you with a unique added value across all these territories and even beyond, through preferred partners in countries not directly covered by PSN Research's parent companies.
Specializations: Clinical studies, Pharmaco-epidemiology, Health economics, Medical Devices, Consulting, Medical Writer, Clinical Evaluation (CEP, CER), CRO, eCRF, IWRS, ePRO and eTMF.
CRO full-service, RCTs accompagne les industriels du médicament, du dispositif médical ainsi que les promoteurs académiques dans leurs projets de recherche.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 15 Oct 2024 | | |
![]() Astellas Pharma Pharmaceutical | Astellas Pharma Pharmaceutical | Other 23 Mar 2024 | | |
![]() CNIL - Commission Nationale de l'Informatique et des Libertés Government Administration | CNIL - Commission Nationale de l'Informatique et des Libertés Government Administration | Other 14 Feb 2024 | | |
![]() Cegedim IT services, IT Services and IT Consulting | Cegedim IT services, IT Services and IT Consulting | Other 14 Feb 2024 | | |
![]() EY Consulting, audit, IT Services and IT Consulting | EY Consulting, audit, IT Services and IT Consulting | Other 23 Feb 2024 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Dec 2023 | | |
![]() KPMG Consulting, audit, Accounting | KPMG Consulting, audit, Accounting | Other 14 Jul 2023 | |